BRAVECTO 40-56 kg

Bravceto

• Due to the rapid onset of action of the product, the risk of transmission of diseases by parasites is significantly reduced
• Product safety was demonstrated in pregnant and breastfeeding treated with an overdose of up to 3 times the maximum recommended dose.
• The product's safety was demonstrated in puppies aged 8-9 weeks and 2-3.6 kg of weight treated with an overdose of up to 5 times the maximum recommended dose on 3 occasions at intervals less (8 weeks) than indicated.
• The product was well tolerated in Collies dogs with multiple drug resistance protein deficiency 1 (MDR1 - / -) following a single administration of 3 times the indicated dose.
• For optimal flea and tick control, the product should be administered at intervals of 12 weeks. Bravecto can be helped throughout the year.